NEW YORK (360Dx) – Vermillion said today that it has received coverage for its OVA1 ovarian cancer test from the Louisiana and Arizona state Medicaid programs.

The company also signed coverage agreements with Joint Venture Hospital Laboratories to provide OVA1 as an in-network benefit to roughly 600,000 BlueCare Network of Michigan members and with QCA Health Plan of Arkansas (Qualchoice) to provide OVA1 coverage to roughly 87,000 lives in that state.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.